Nearly one in three Americans over the age of 60 — roughly 19 million people — take aspirin daily, according to a 2021 study.

Daily low-dose aspirin reduced the risk for colorectal cancer recurrence by roughly half in patients with mutations in the ...

Racial minorities and people on Medicaid were still taking baby aspirin in 2021-2023 despite guideline warnings. (JAMA) For ...

SAN FRANCISCO -- In an era dominated by pricey, high-tech drugs, the humble aspirin had a practice-changing impact on ...

Is daily aspirin really necessary for heart disease prevention? Find out the truth behind the changing recommendations.

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.

A new study published in the Nature Scientific Reports highlighted the potential benefits of aspirin in reducing biochemical recurrence (BCR) rates following robot-assisted radical ...

Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in the PI3K ...

Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance ...

After guideline changes, aspirin use dropped off overall, even for higher-risk patients in whom it might still be considered.

Among older adults and adults with low ASCVD risk for whom aspirin is not recommended, use of aspirin decreased after 2019 ...